Johannes Lauenstein

Johannes Lauenstein is a Senior Associate at Oberland Capital, where Johannes focuses on Biopharma, Healthcare, and Private Equity. Prior to this role, Johannes worked as a Project Leader at Boston Consulting Group (BCG). Johannes holds a PhD in Biochemistry from the University of Cambridge, a Master of Science in Biochemistry & Biotechnology from Ghent University, and a Bachelor of Science in Biochemistry & Biotechnology from Ghent University.